MIT-001
MitoImmune Therapeutics
MitoImmune Therapeutics
EpicentRx, Inc.
EpicentRx, Inc.
MitoImmune Therapeutics
Enzychem Lifesciences Corporation
US Oncology Research
Galera Therapeutics, Inc.
Santalis Pharmaceuticals, Inc.
CSL Behring
Oragenics, Inc.
Oral Defense, LLC
Innovation Pharmaceuticals, Inc.
Ingalfarma SpA
Catalysis SL
Izun Pharma Ltd
Soligenix
Celldex Therapeutics
Swedish Orphan Biovitrum
Mucosal Therapeutics
RxKinetix